31694701|t|Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease.
31694701|a|To date, the development of disease-modifying therapies for Alzheimer's disease (AD) has largely focused on the removal of amyloid beta Abeta fragments from the CNS. Proteomic profiling of patient fluids may help identify novel therapeutic targets and biomarkers associated with AD pathology. Here, we applied the Olink  ProSeek immunoassay to measure 270 CSF and plasma proteins across 415 Abeta- negative cognitively normal individuals (Abeta- CN), 142 Abeta-positive CN (Abeta+ CN), 50 Abeta- mild cognitive impairment (MCI) patients, 75 Abeta+ MCI patients, and 161 Abeta+ AD patients from the Swedish BioFINDER study. A validation cohort included 59 Abeta- CN, 23 Abeta- + CN, 44 Abeta- MCI and 53 Abeta+ MCI. To compare protein concentrations in patients versus controls, we applied multiple linear regressions adjusting for age, gender, medications, smoking and mean subject-level protein concentration, and corrected findings for false discovery rate (FDR, q < 0.05). We identified, and replicated, altered levels of ten CSF proteins in Abeta+ individuals, including CHIT1, SMOC2, MMP-10, LDLR, CD200, EIF4EBP1, ALCAM, RGMB, tPA and STAMBP (- 0.14 < d < 1.16; q < 0.05). We also identified and replicated alterations of six plasma proteins in Abeta+ individuals OSM, MMP-9, HAGH, CD200, AXIN1, and uPA (- 0.77 < d < 1.28; q < 0.05). Multiple analytes associated with cognitive performance and cortical thickness (q < 0.05). Plasma biomarkers could distinguish AD dementia (AUC = 0.94, 95% CI = 0.87-0.98) and prodromal AD (AUC = 0.78, 95% CI = 0.68-0.87) from CN. These findings reemphasize the contributions of immune markers, phospholipids, angiogenic proteins and other biomarkers downstream of, and potentially orthogonal to, Abeta- and tau in AD, and identify candidate biomarkers for earlier detection of neurodegeneration.
31694701	73	92	Alzheimer's disease	Disease	MESH:D000544
31694701	154	173	Alzheimer's disease	Disease	MESH:D000544
31694701	175	177	AD	Disease	MESH:D000544
31694701	217	229	amyloid beta	Gene	351
31694701	230	235	Abeta	Gene	351
31694701	283	290	patient	Species	9606
31694701	373	375	AD	Disease	MESH:D000544
31694701	485	490	Abeta	Gene	351
31694701	533	538	Abeta	Gene	351
31694701	549	554	Abeta	Gene	351
31694701	568	573	Abeta	Gene	351
31694701	583	588	Abeta	Gene	351
31694701	595	615	cognitive impairment	Disease	MESH:D003072
31694701	617	620	MCI	Disease	MESH:D060825
31694701	622	630	patients	Species	9606
31694701	635	640	Abeta	Gene	351
31694701	642	645	MCI	Disease	MESH:D060825
31694701	646	654	patients	Species	9606
31694701	664	669	Abeta	Gene	351
31694701	671	673	AD	Disease	MESH:D000544
31694701	674	682	patients	Species	9606
31694701	749	754	Abeta	Gene	351
31694701	763	768	Abeta	Gene	351
31694701	779	784	Abeta	Gene	351
31694701	786	789	MCI	Disease	MESH:D060825
31694701	797	802	Abeta	Gene	351
31694701	804	807	MCI	Disease	MESH:D060825
31694701	846	854	patients	Species	9606
31694701	1139	1144	Abeta	Gene	351
31694701	1169	1174	CHIT1	Gene	1118
31694701	1176	1181	SMOC2	Gene	64094
31694701	1183	1189	MMP-10	Gene	4319
31694701	1191	1195	LDLR	Gene	3949
31694701	1197	1202	CD200	Gene	4345
31694701	1204	1212	EIF4EBP1	Gene	1978
31694701	1214	1219	ALCAM	Gene	214
31694701	1221	1225	RGMB	Gene	285704
31694701	1227	1230	tPA	Gene	5327
31694701	1235	1241	STAMBP	Gene	10617
31694701	1345	1350	Abeta	Gene	351
31694701	1369	1374	MMP-9	Gene	4318
31694701	1376	1380	HAGH	Gene	3029
31694701	1382	1387	CD200	Gene	4345
31694701	1389	1394	AXIN1	Gene	8312
31694701	1400	1403	uPA	Gene	118471
31694701	1562	1573	AD dementia	Disease	MESH:D000544
31694701	1621	1623	AD	Disease	MESH:D000544
31694701	1730	1743	phospholipids	Chemical	MESH:D010743
31694701	1832	1837	Abeta	Gene	351
31694701	1843	1846	tau	Gene	4137
31694701	1850	1852	AD	Disease	MESH:D000544
31694701	1913	1930	neurodegeneration	Disease	MESH:D019636
31694701	Association	118471	351
31694701	Association	1118	351
31694701	Association	351	4319
31694701	Association	1978	351
31694701	Association	351	64094
31694701	Association	214	351
31694701	Association	351	8312
31694701	Association	285704	351
31694701	Association	351	3949
31694701	Association	10617	351
31694701	Association	351	4318
31694701	Association	351	4345
31694701	Association	351	5327

